Table 6.
Regression model outputs in PD: CSF biomarkers (pg/mL).
Model | a-Synuclein (a-syn) | Amyloid-b | CSF p-tau (2016 assay) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PD | PD-F | PD-M | PD-M* | PD | PD-F | PD-M | PD-M* | PD | PD-F | PD-M | PD-M* | ||
R2 | 0.092 | 0.234 | 0.033 | 0.034 | 0.045 | 0.089 | 0.028 | 0.020 | 0.08 | 0.11 | 0.07 | 0.06 | |
F (p-value†) | 6.091 (<0.001) | 9.350 (<0.001) | 1.540 (0.219) | 1.062 (0.399) | 2.746 (0.018) | 2.882 (0.034) | 1.645 (0.191) | 0.612 (0.663) | 4.824 (<0.001) | 3.603 (0.013) | 4.085 (0.005) | 1.668 (0.191) | |
Brain-PAD | b | −15.45 | −32.68 | −8.89 | −10.69 | −10.39 | −19.479 | −6.897 | −7.799 | −0.050 | −0.160 | −0.015 | 0.049 |
t | −3.117 | −3.644 | −1.517 | −1.251 | −3.280 | −2.890 | −2.010 | −1.505 | −1.206 | −1.753 | −0.328 | 0.707 | |
p | 0.002 | <0.001 | 0.131 | 0.213 | 0.001 | 0.005 | 0.046 | 0.135 | 0.229 | 0.082 | 0.743 | 0.481 | |
Actual age | b | 10.51 | 15.43 | 8.042 | 5.669 | 0.577 | 0.849 | 0.651 | −0.097 | 0.135 | 0.168 | 0.122 | 0.101 |
t | 2.988 | 2.624 | 1.866 | 0.977 | 0.256 | 0.190 | 0.259 | −0.028 | 4.684 | 2.893 | 3.837 | 2.126 | |
p | 0.003 | 0.010 | 0.063 | 0.331 | 0.798 | 0.850 | 0.796 | 0.978 | <0.001 | 0.005 | <0.001 | 0.035 | |
Duration | b | 12.13 | 27.21 | 0.624 | 11.672 | 0.944 | 9.153 | −4.865 | −1.162 | 0.024 | 0.106 | −0.047 | 0.058 |
t | 2.330 | 3.580 | 0.090 | 1.238 | 0.283 | 1.583 | −1.204 | −0.203 | 0.565 | 1.501 | −0.903 | 0.523 | |
p | 0.020 | <0.001 | 0.928 | 0.218 | 0.777 | 0.116 | 0.230 | 0.839 | 0.573 | 0.136 | 0.368 | 0.601 | |
Education | b | −3.129 | 4.472 | −6.392 | −13.122 | −4.139 | 5.271 | −9.018 | −5.135 | 0.067 | 0.050 | 0.080 | 0.110 |
t | −0.262 | 0.227 | −0.433 | −0.697 | −0.544 | 0.355 | −1.051 | −0.452 | 0.696 | 0.269 | 0.736 | 0.676 | |
p | 0.794 | 0.821 | 0.666 | 0.487 | 0.587 | 0.723 | 0.294 | 0.652 | 0.487 | 0.789 | 0.462 | 0.500 | |
Sex | b | 106.4 | – | – | – | 26.29 | – | – | – | 0.543 | – | – | – |
t | 1.466 | – | – | – | 0.564 | – | – | – | 0.922 | – | – | – | |
p | 0.144 | – | – | – | 0.573 | – | – | – | 0.357 | – | – | – |
PD Parkinson’s disease, F females, M males, M* matched males. Significant results are highlighted in bold. †The p-values of the F-statistics were adjusted for multiple comparisons using the FDR technique.